142 related articles for article (PubMed ID: 11992835)
1. Extracorporeal shock wave therapy in the treatment of Peyronie's disease: experience with standard lithotriptor (siemens-multiline).
Lebret T; Loison G; Hervé JM; Mc Eleny KR; Lugagne PM; Yonneau L; Orsoni JL; Saporta F; Butreau M; Botto H
Urology; 2002 May; 59(5):657-61. PubMed ID: 11992835
[TBL] [Abstract][Full Text] [Related]
2. Extracorporeal shockwave therapy for Peyronie's disease: an alternative treatment?
Poulakis V; Skriapas K; de Vries R; Dillenburg W; Ferakis N; Witzsch U; Melekos M; Becht E
Asian J Androl; 2006 May; 8(3):361-6. PubMed ID: 16625288
[TBL] [Abstract][Full Text] [Related]
3. Extracorporeal shockwave therapy for Peyronie's disease does not correct penile deformity.
Strebel RT; Suter S; Sautter T; Hauri D
Int J Impot Res; 2004 Oct; 16(5):448-51. PubMed ID: 14973523
[TBL] [Abstract][Full Text] [Related]
4. Extracorporeal shock wave therapy in the management of Peyronie's disease: initial experience.
Husain J; Lynn NN; Jones DK; Collins GN; O'Reilly PH
BJU Int; 2000 Sep; 86(4):466-8. PubMed ID: 10971273
[TBL] [Abstract][Full Text] [Related]
5. Tadalafil once daily and extracorporeal shock wave therapy in the management of patients with Peyronie's disease and erectile dysfunction: results from a prospective randomized trial.
Palmieri A; Imbimbo C; Creta M; Verze P; Fusco F; Mirone V
Int J Androl; 2012 Apr; 35(2):190-5. PubMed ID: 22085227
[TBL] [Abstract][Full Text] [Related]
6. Extracorporeal shock wave therapy in Peyronie's disease: results of a placebo-controlled, prospective, randomized, single-blind study.
Hatzichristodoulou G; Meisner C; Gschwend JE; Stenzl A; Lahme S
J Sex Med; 2013 Nov; 10(11):2815-21. PubMed ID: 23898925
[TBL] [Abstract][Full Text] [Related]
7. Shockwave therapy as first-line treatment for Peyronie's disease: a prospective study.
Skolarikos A; Alargof E; Rigas A; Deliveliotis Ch; Konstantinidis E
J Endourol; 2005; 19(1):11-4. PubMed ID: 15735375
[TBL] [Abstract][Full Text] [Related]
8. Long-term results of extracorporeal shockwave therapy for Peyronie's disease.
Srirangam SJ; Manikandan R; Hussain J; Collins GN; O'Reilly PH
J Endourol; 2006 Nov; 20(11):880-4. PubMed ID: 17144855
[TBL] [Abstract][Full Text] [Related]
9. Questionable efficacy of extracorporeal shock wave therapy for Peyronie's disease: results of a prospective approach.
Hauck EW; Hauptmann A; Bschleipfer T; Schmelz HU; Altinkilic BM; Weidner W
J Urol; 2004 Jan; 171(1):296-9. PubMed ID: 14665898
[TBL] [Abstract][Full Text] [Related]
10. A first prospective, randomized, double-blind, placebo-controlled clinical trial evaluating extracorporeal shock wave therapy for the treatment of Peyronie's disease.
Palmieri A; Imbimbo C; Longo N; Fusco F; Verze P; Mangiapia F; Creta M; Mirone V
Eur Urol; 2009 Aug; 56(2):363-9. PubMed ID: 19473751
[TBL] [Abstract][Full Text] [Related]
11. Extracorporeal Shockwave Therapy in Peyronie's Disease: Systematic Review and Meta-Analysis.
Bakr AM; El-Sakka AI
J Sex Med; 2021 Oct; 18(10):1705-1714. PubMed ID: 34511369
[TBL] [Abstract][Full Text] [Related]
12. Shockwave Therapy in the Treatment of Peyronie's Disease.
Krieger JR; Rizk PJ; Kohn TP; Pastuszak A
Sex Med Rev; 2019 Jul; 7(3):499-507. PubMed ID: 30926460
[TBL] [Abstract][Full Text] [Related]
13. [Low-intensity extracorporeal shockwave therapy for Peyronie's disease: A preliminary study of 32 cases].
Li PC; Chen X; Zhu XB; Shi T; Song F; Huang HW; Zhang XS
Zhonghua Nan Ke Xue; 2018 Apr; 24(4):340-344. PubMed ID: 30168955
[TBL] [Abstract][Full Text] [Related]
14. [Extra-corporeal lithotripsy in the treatment of Peyronie's disease. Use of a standard lithotriptor (Multiline Siemens) on "young" (less then 6 months old) plaques].
Lebret T; Hervé JM; Lugagne PM; Barré P; Orsini JL; Butreau M; Botto H
Prog Urol; 2000 Feb; 10(1):65-70; discussion 70-1. PubMed ID: 10785921
[TBL] [Abstract][Full Text] [Related]
15. Long-term experiences with high-energy shock wave therapy in the management chronic phase Peyronie's disease using two different electromagnetic lithotripters.
Rassweiler JJ; Scheitlin W; Goezen AS; Radecke F
World J Urol; 2024 Mar; 42(1):124. PubMed ID: 38453751
[TBL] [Abstract][Full Text] [Related]
16. Evaluation of extracorporeal shock wave therapy in Peyronie's disease.
Manikandan R; Islam W; Srinivasan V; Evans CM
Urology; 2002 Nov; 60(5):795-9; discussion 799-800. PubMed ID: 12429298
[TBL] [Abstract][Full Text] [Related]
17. Low-intensity laser diode plus extracorporeal shock wave therapy: a new treatment strategy in the management of Peyronie's disease.
Dell'Atti L; Ronchi P
World J Urol; 2023 Sep; 41(9):2563-2568. PubMed ID: 37490060
[TBL] [Abstract][Full Text] [Related]
18. An alternative non-invasive treatment for Peyronie's disease.
Claro JA; Passerotti CC; Figueiredo Neto AC; Nardozza A; Ortiz V; Srougi M
Int Braz J Urol; 2004; 30(3):199-204; discussion 204. PubMed ID: 15689246
[TBL] [Abstract][Full Text] [Related]
19. Extracorporeal shock wave therapy (ESWT) in urology: a systematic review of outcome in Peyronie's disease, erectile dysfunction and chronic pelvic pain.
Fojecki GL; Tiessen S; Osther PJ
World J Urol; 2017 Jan; 35(1):1-9. PubMed ID: 27108421
[TBL] [Abstract][Full Text] [Related]
20. [Peyronie's disease: ultrasonographic follow-up of ESWT].
Colombo F; Nicola M
Arch Ital Urol Androl; 2000 Dec; 72(4):388-91. PubMed ID: 11221077
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
